Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2021-10-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
전환가액의조정(제8회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by Jeonjin BioPharm. It details the change in conversion price, the number of convertible shares, and the underlying reasons (market price decline). This type of disclosure regarding capital structure changes, specifically related to convertible securities, falls under the 'Capital/Financing Update' category.
2021-10-12 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Jeonjin Bio Pharm Co., Ltd. for the period ending June 30, 2021. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including call options on convertible bonds, by major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-07-15 Korean
증권발행결과(자율공시)(제8회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the final issuance amount, payment date, and method. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2021-07-09 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, conversion prices, put/call options, and the use of proceeds. This type of filing, which concerns capital structure changes and financing activities, is classified as a Capital/Financing Update.
2021-07-07 Korean
[기재정정]전환청구권행사(제7회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Jeonjin BioPharm regarding the exercise of conversion rights (conversion of convertible bonds into shares). It details the number of shares issued, the conversion price, and the updated listing date. This type of corporate action, involving the issuance of new shares resulting from the conversion of debt, falls under the category of share issuance or capital changes.
2021-06-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.